US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million
U.S.-based pharmaceutical company Gilead Sciences has announced plans to acquire MiroBio, an Oxford University biotech spin-off, for $405 million in cash. MiroBio’s research technology and portfolio of immunosuppressive receptor agonists will be acquired by Gilead. Acquisition The acquisition will be completed after the expiration or completion of the Hart-Scott-Rodino Antitrust Improvements Act waiting period and […]
